Riskpilot← Back to searchSign inGet full accessAPOTEK 1 GAUSDAL AS
ASActiveOrg 884349842Skårersletta 55, 1473 LørenskogRetail sale of pharmaceutical products · NACE 4773Est. 200217 employees
Revenue 2023
NOK 2,4M
-92% vs 2022
EBITDA margin
-0.3%
-101% vs 2022
Equity ratio
33.2%
Financial strength
Net profit 2023
NOK -10K
-101% vs 2022
| Revenue | NOK 2,4M | -92% |
| EBITDA | NOK -7K | -101% |
| Net profit | NOK -10K | -101% |
| Total assets | NOK 10,1M | +45% |
| Equity | NOK 3,3M | +0% |
| Employees | 17 | — |
Legal name
APOTEK 1 GAUSDAL AS
Org number
884349842
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
21. mars 2002
Share capital
NOK 40 000 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-01-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Apotekdrift.
Address
Skårersletta 55, 1473 Lørenskog
Phone
+4761229390
Email
kontakt@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 20 856 | 24 128 | 28 097 | 28 183 | 2 386 |
| Staff expenses | −3 888 | −4 124 | −4 208 | −4 276 | −375 |
| EBITDA | 528 | 1 251 | 2 092 | 1 368 | −7 |
| Depreciation & amort. | −194 | −192 | −96 | −14 | −4 |
| EBIT | 333 | 1 058 | 1 997 | 1 354 | −11 |
| Net financials | 1 | 11 | 5 | 17 | 0 |
| Profit before tax | 334 | 1 069 | 2 001 | 1 371 | −11 |
| Tax | 75 | 237 | 441 | 305 | −1 |
| Net profit | 259 | 832 | 1 560 | 1 066 | −10 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 7 140 | 7 039 | 8 889 | 6 948 | 10 062 |
| Equity | 2 364 | 2 726 | 2 286 | 3 352 | 3 342 |
| Long-term debt | 0 | 0 | 0 | 29 | 28 |
| Short-term debt | 4 776 | 4 313 | 6 571 | 3 567 | 6 692 |
| Total debt | 4 776 | 4 313 | 6 603 | 3 596 | 6 720 |
EBITDA margin
-0.3%
This company
15.8%
Market median
-102% vs market
20192023
Equity ratio
33.2%
This company
38.2%
Market median
+13% vs market
20192023
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20192023
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20192023
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20192023
Debt / equity
2.01×
This company
0.62×
Market median
-224% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
IH Chief Executive Officer | Chief Executive Officer | 2002 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2002 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Phoenix Norwegian Holding As
APOTEK 1 GAUSDAL AS Board members of APOTEK 1 GAUSDAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingunn Heggen | Chief Executive Officer | 0 companies |
| Børge Moholt | Chairman | 0 companies |
| Øystein Askim | Board of Directors | 0 companies |
| Jon Egil Hage | Chairman | 0 companies |